The Liver Meeting 2020-Hepatobiliary Neoplasia SIG & Liver Transplantation and Surgery SIG - Part 1 Hot Topics in the Pathogenesis and Treatment of Liver Cancer (HCC and iCCA)

Hepatobiliary Neoplasia SIG & Liver Transplantation and Surgery SIG - Part 1 Hot Topics in the Pathogenesis and Treatment of Liver Cancer (HCC and iCCA)

Back to course

Video Transcription

Video Summary

The symposium focused on hot topics in the pathogenesis and treatment of liver cancer, specifically hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Dr. Lelievre and Dr. Shielski chaired the session, discussing the pathogenesis and treatment options for early tumors and advanced tumors. Presentations included targeting the FGF map kinase axis in basal carcinoma, comparing resection versus transplant for intrahepatic angiocarcinoma, and management improvements with local-regional therapies by Dr. Laura Cooley. Dr. Heimbach discussed resection versus transplant for intrahepatic cholangiocarcinoma, emphasizing the importance of patient selection and treatment outcomes. Dr. Cooley highlighted advancements in local-regional therapies, such as Y90 radioembolization and SBRT, demonstrating improved survival rates in patients with hepatocellular carcinoma. The symposium also addressed innovative approaches combining local therapies with immunotherapy for potential improved efficacy in treating liver cancer. This multidisciplinary collaboration and personalized treatment strategies aim to enhance patient outcomes and further research in liver cancer treatment options.

Keywords

liver cancer

hepatocellular carcinoma

intrahepatic cholangiocarcinoma

FGF map kinase axis

resection versus transplant

local-regional therapies

Y90 radioembolization

SBRT

immunotherapy